Eligibility Criteria

Individuals diagnosed with mild, early-stage dementia.
Caregivers may participate to support individuals meeting the above criteria.
Participants must be able to engage in a 60-90 minute session, either in person or via Zoom.

Eligibility Criteria

You are eligible to participate in this study if you are:

• A healthy young adult aged 18-35, a healthy older adult aged 65 and up, or an older adult with mild/early-stage dementia as diagnosed by your doctor
• Able to provide written, informed consent to participate
• Have normal or corrected-to-normal hearing in both ears and vision in both eyes
• You must have no history of cerebro-vascular injury or accident (such as a stroke)
• For adults without dementia, you must have no known neurological conditions and must not be taking any neuroactive drugs

You will not be eligible to participate in the study if you:

• Have metallic objects that cannot be removed for the MEG recording (such as permanent piercings and medical implants that are made from magnetic metals)
• Are pregnant
• Feel you cannot perform the audio-visual and/or music listening tasks

Eligibility Criteria

You are eligible to participate if you speak English as a primary language, a confirmed diagnosis of PPA in mild to moderate impairment stage, a communication partner that is willing to participate, and sufficient internet connection.

Eligibility Criteria

You are eligible to participate if you…

1.) Diagnosed with Dementia and/or memory loss by a clinician

2.) Exhibit adequate oral communication skills and cognitive function sufficient to obtain a score ranging between 10-27 on the Mini-Mental State Exam

3.) Walk or stand with or without personnel or assistive devices

4.) Individuals must be greater than or equal to 50 years of age

Eligibility Criteria

You are eligible to participate if you:

- are a French-English bilingual over the age of 65

- have mild cognitive impairment

- have Alzheimer's disease

- are a healthy older adult (i.e., have no cognitive conditions)

Please note that you do not need to be completely fluent in both English and French, just to have some familiarity, experience or training with both languages to be eligible to participate.

Thank you for your consideration!

Eligibility Criteria

- Age 18 years or older

- Reside in Canada

- Have access to a computer/touchscreen device

- Can provide informed consent

- Do not have a diagnosis of dementia

- Additionally, we are enrolling participants who have previously or currently care for persons with dementia for caregiver-specific assessments

- Ability to speak English

Eligibility Criteria

You are eligible to participate if you meet the following criteria:

• Age ≥ 55; females must be post-menopausal

• DSM-5 criteria for Major Neurocognitive Disorder due to AD; multiple etiologies (AD and vascular)

• sMMSE ≤ 24

• Clinically significant agitation based on IPA definition

• Stable cognition-enhancing medication for at least 3 months prior to study enrolment

• Availability of a caregiver to accompany participant to study visits and to participate in the study

• Ability to speak English

Eligibility Criteria

- are a primary family caregiver of a person with dementia or a related neurodegenerative disorder.

- have access to a computer with high-speed internet; and feel comfortable using email and Zoom (a secure online meeting platform).

- have a video camera on your device. To ensure safety of participants during the program sessions, it is important that participants turn on their video camera. Keeping the video camera on is also important to build trust within the group sessions and when interacting with the researchers.

- are willing to be randomised to one of 3 groups, even if it is not your preferred group.

- are able to commit to a synchronous 8-week online group-based program (described below) and complete daily prescribed daily home practices.

- are able to commit to three assessment sessions: one baseline assessment, one post-program assessment, one 12-month follow-up assessment.

- agree to audio recording of interview sessions and portions of the assessment that require accurate verbal data collection.

- are able to provide blood samples, potentially after a 12-hour fast.

- are able to travel to a LifeLabs clinic for biomarker collection.

- agree to refrain from participating in new studies or programs during the 8-week study session.

- meet the screening criteria during the pre-screening interview.

- ability to speak English.

Eligibility Criteria

Are a member of the TRIAD cohort at McGill University, falling within one of the following categories: young control, cognitively unimpaired, mild cognitive impairment, or Alzheimer's Disease.

Are willing and able to undergo advanced neuroimaging techniques including MRI and PET without contraindications.

Have not had any significant neurological conditions (other than AD for the AD group) that might interfere with the results of the study.

Have no metal implants, devices, or other conditions that may contraindicate or distort MRI imaging.

Are not currently participating in other clinical trials or studies that involve interventions which might interfere with the results of this study.

Are able and willing to provide informed consent for participation in the study or have a legally authorized representative who can do so.

Do not have a history of substance abuse or other conditions that might confound the imaging and cognitive data.

Have not undergone any significant head trauma or surgery in the past 6 months.

Are not pregnant or planning to become pregnant during the duration of the study.

Are willing to comply with all study-related procedures, imaging sessions, and follow-up evaluations.

Ability to speak English and French